MedPath
TGA Approval

VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle (286358)

286358

VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle

Gilead Sciences Pty Ltd

March 16, 2018

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/ca6a6a6947cad5ffe19c7cc58231e115.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/7fcad62a9a1eb944ffd468fd0638ec9e.pdf

Active Ingredients

sofosbuvir

velpatasvir

voxilaprevir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle (286358) - TGA 批准文号 | MedPath